Literature DB >> 33088819

Lightning-Storm Periungual Capillaries in a Patient with Complex Regional Pain Syndrome Type I.

Mariana Perez1, Thomas Vazquez1, Agnese Canazza2, Martin Zaiac1,2.   

Abstract

INTRODUCTION: Complex regional pain syndrome (CRPS) is characterized by chronic pain out of proportion to injury following trauma. CRPS most commonly results after crush-type injury to the hand and may be associated with various cutaneous symptoms believed to be driven by vasomotor instability. Existing reports in the literature have employed a range of methodologies to describe and evaluate cutaneous and vascular changes in CRPS, though there exists no current gold standard for diagnosis. CASE
PRESENTATION: Here, we report a 71-year-old male with a 10-year history of CRPS who presented with abnormal capillaries on onychoscopy, demonstrating a "lightning-storm" pattern.
CONCLUSION: Previous studies have shown increased blood flow to the cutis in the early stage of CRPS, yet diminished cutaneous flow during the later stages. However, one study showed increased nail capillary diameter in patients with later stage CRPS. Due to a variety of reported clinical characteristics and a nonspecific clinic presentation, both the recognition and diagnosis of CRPS is difficult. Nail fold capillaroscopy may be a useful and accessible tool for evaluating patients with CRPS.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Capillaroscopy; Complex regional pain syndrome; Onychoscopy; Periungual capillaries

Year:  2020        PMID: 33088819      PMCID: PMC7548890          DOI: 10.1159/000507901

Source DB:  PubMed          Journal:  Skin Appendage Disord        ISSN: 2296-9160


  16 in total

1.  The reflex sympathetic dystrophy syndrome (RSDS). III. Scintigraphic studies, further evidence for the therapeutic efficacy of systemic corticosteroids, and proposed diagnostic criteria.

Authors:  F Kozin; L M Ryan; G F Carerra; J S Soin; R L Wortmann
Journal:  Am J Med       Date:  1981-01       Impact factor: 4.965

2.  Diagnostic criteria for CRPS I: differences between patient profiles using three different diagnostic sets.

Authors:  Roberto S G M Perez; Susan Collins; Johan Marinus; Wouter W A Zuurmond; Jaap J de Lange
Journal:  Eur J Pain       Date:  2007-04-02       Impact factor: 3.931

Review 3.  A hypothesis for the cause of complex regional pain syndrome-type I (reflex sympathetic dystrophy): pain due to deep-tissue microvascular pathology.

Authors:  Terence J Coderre; Gary J Bennett
Journal:  Pain Med       Date:  2010-08       Impact factor: 3.750

4.  Clinical presentation of cutaneous manifestations in complex regional pain syndrome (type 1).

Authors:  Basak Kandi; Arzu Kaya; Dilara Turgut; Salih Ozgocmen; Demet Cicek
Journal:  Skinmed       Date:  2007 May-Jun

5.  Reflex sympathetic dystrophy: evolution of microcirculatory disturbances in time.

Authors:  H A Kurvers; M J Jacobs; R J Beuk; F A Van den Wildenberg; P J Kitslaar; D W Slaaf; R S Reneman
Journal:  Pain       Date:  1995-03       Impact factor: 6.961

6.  Reflex sympathetic dystrophy with prominent involvement of the nail apparatus.

Authors:  A Tosti; R Baran; A M Peluso; P A Fanti; R Liguori
Journal:  J Am Acad Dermatol       Date:  1993-11       Impact factor: 11.527

Review 7.  Complex regional pain syndrome: a review.

Authors:  J Field
Journal:  J Hand Surg Eur Vol       Date:  2013-01-22

8.  Unilateral trachyonychia in a patient with reflex sympathetic dystrophy.

Authors:  Brian Pucevich; Lori Spencer; Joseph C English
Journal:  J Am Acad Dermatol       Date:  2008-02       Impact factor: 11.527

9.  Skin microvascular circulation in the sympathetic dystrophies evaluated by videophotometric capillaroscopy and laser Doppler fluxmetry.

Authors:  L Rosén; J Ostergren; B Fagrell; E Stranden
Journal:  Eur J Clin Invest       Date:  1988-06       Impact factor: 4.686

10.  Complex Regional Pain Syndrome: What the Dermatologist Should Know.

Authors:  Azam A Qureshi; Adam J Friedman
Journal:  J Drugs Dermatol       Date:  2018-05-01       Impact factor: 2.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.